Koers CannTrust Holdings Inc Canadian Securities Exchange
Aandelen
TRST
CA1378002077
Farmaceutische producten
Omzet 2017 | 20,7 28,17 19,05 | Omzet 2018 | 45,65 62,12 42 | Marktkapitalisatie | 508 mln. 692 mln. 468 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2017 | 6 mln. 8,17 mln. 5,52 mln. | Nettowinst (verlies) 2018 | -13 mln. -17,69 mln. -11,96 mln. | EV/omzet 2017 | 31.215.427 x |
Nettoliquiditeiten 2017 | 17,16 mln. 23,36 mln. 15,79 mln. | Nettoliquiditeiten 2018 | 58 mln. 78,93 mln. 53,37 mln. | EV/omzet 2018 | 9.864.003 x |
K/w-verhouding 2017 |
81,5
x | K/w-verhouding 2018 |
-34,5
x | Werknemers | - |
Dividendrendement 2017 * |
-
| Dividendrendement 2018 |
-
| Vrij verhandelbaar | 100% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Greg Guyatt
CEO | Chief Executive Officer | - | 19-02-19 |
David Blair
DFI | Director of Finance/CFO | - | 01-10-19 |
Sales & Marketing | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Greg Guyatt
CEO | Chief Executive Officer | - | 19-02-19 |
Dan Hogan
BRD | Director/Board Member | - | 17-03-21 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+42,38% | 6,26 mld. | |
-15,86% | 4,49 mld. | |
+6,36% | 3,29 mld. | |
-11,28% | 3,12 mld. | |
-3,23% | 2,5 mld. | |
+45,24% | 1,94 mld. | |
-7,89% | 1,68 mld. | |
-0,98% | 1,63 mld. | |
-11,32% | 1,56 mld. |